Sort   by:  
 Page size 
MetabolomicsLive Combined Bifidobacterium Attenuates Rivaroxaban-Associated Colonic Bleeding in Mice: Evidence for a Substantial Gut Microbiota-Dependent Component
This study investigated fecal metabolic alterations associated with live combined Bifidobacterium (LCB) treatment in a mouse model of rivaroxaban-associated colonic bleeding. Male C57BL/6J mice were included in two experiments comprising normal control, rivaroxaban-treated, rivaroxaban followed by L...
2026-10-09 | MTBLS15531 | MetaboLights
ProteomicsMetabolomics analysis of Rivaroxaban
In this study, plasma metabolomes before and 3 hours after rivaroxaban intake in nonvalvular atrial ûbrillation (NVAF) patients and age/gender-matched controls were analyzed by liquid chromatography coupled with mass spectrometry (LC3MS/MS).
ORGANISM(S): Homo Sapiens 
2022-07-24 | PXD032247 |
ClinicalRivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.
Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study.
2236844 | ecrin-mdr-crc
ModelsOrfeo2010 - Simulating the effects of fondaparinux and Rivaroxaban on thrombin generation
Reused mathematical model (Hockin et al., 2002) of blood coagulation simulating the effects of coagulation factor inhibitors, fondaparinux (synthetic heparin) and Rivaroxaban. Fondaparinux (Fpx) simulated to reversibly bind with ATIII before irreversibly binding to Xa, IXa, mIIa, TF:VIIa, Xa:Va and ...
2018-07-24 | MODEL1807240001 | BioModels
ProteomicsLabel-Free Quantitative LC-MS/MS Proteomic Profiling of Human Umbilical Vein Endothelial Cells Treated with Direct Oral Anticoagulants
This dataset contains label-free quantitative (LFQ) LC-MS/MS proteomics data generated from human umbilical vein endothelial cells (HUVECs) treated with therapeutically relevant concentrations of the direct oral anticoagulants (DOACs) apixaban, rivaroxaban, edoxaban, and dabigatran, together with un...
ORGANISM(S): Homo sapiens (Human) 
2026-10-22 | PXD082155 | Pride
Apixaban Q exactive Endothelial cells Rivaroxaban Direct oral anticoagulants Lc-ms/ms Dabigatran Edoxaban Proteome discoverer2.5 Proteomics Lfq Huvec Label-free quantification 
ClinicalA comparison between rivaroxaban and placebo for the prevention of deep vein thrombosis or pulmonary embolism afetr laparoscpic surgery for colorectal cancer after initial heparin prophylaxis
Primary objectives: To assess the efficacy and safety of postdischarge extended (3 weeks) antithrombotic prophylaxis with rivaroxaban compared to placebo after planned laparoscopic surgery for colorectal cancer in patients who had received antithrombotic prophylaxis with LMWH during the hospital sta...
2535176 | ecrin-mdr-crc
ModelsBurghaus2011 - Simulating Rivaroxaban effects on blood coagulation
Another mathematical model of blood coagulation.
2018-05-21 | MODEL1805140001 | BioModels
Genomics
16S rRNA Gene Sequencing of the Gut Microbiota in a Mouse Model of Rivaroxaban-Associated Colonic Bleeding Treated With Live Combined Bifidobacterium
PRJNA1507308 | ENA
UnknownMonitoring of Rivaroxaban Therapy in Hypercoagulable Dogs.
Not available
S-EPMC11836667 | biostudies-literature
UnknownRivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.
Not available
S-EPMC5710243 | biostudies-literature
Sort   by:  
 Page size